Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
Add more filters










Publication year range
1.
Eur J Med Chem ; 149: 22-29, 2018 Apr 10.
Article in English | MEDLINE | ID: mdl-29494842

ABSTRACT

Nowadays, the pharmacological therapy for the treatment of Chagas disease is based on two old drugs, benznidazole and nifurtimox, which have restricted efficacy against the chronic phase of the illness. To overcome the lack of efficacy of the traditional drugs (and their considerable toxicity), new molecular targets have been studied as starting points to the discovery of new antichagasic compounds. Among them, polyamine transporter TcPAT12 (also known as TcPOT1.1) represents an interesting macromolecule, since polyamines are essential for Trypanosoma cruzi, the parasite that causes the illness, but it cannot synthesize them de novo. In this investigation we report the results of a combined ligand- and structure-based virtual screening for the discovery of new inhibitors of TcPAT12. Initially we filtered out ZINC and Drugbank databases with similarity and QSAR models and then we submitted the candidates to a validated docking based screening. Four structures were selected and tested in T. cruzi epimastigotes proliferation and two of them, Cisapride and [2-(cyclopentyloxy)phenyl]methanamine showed inhibitory effects. Additionally, we performed transport assays which demonstrated that Cisapride interferes with putrescine uptake in a specific mode.


Subject(s)
Chagas Disease/drug therapy , Cisapride/pharmacology , Protozoan Proteins/antagonists & inhibitors , Putrescine/antagonists & inhibitors , Trypanosoma cruzi/drug effects , Biological Transport/drug effects , Cisapride/therapeutic use , Drug Evaluation, Preclinical/methods , Ligands , Membrane Transport Proteins/drug effects , Molecular Docking Simulation/methods , Molecular Structure , Polyamines/pharmacokinetics , Putrescine/pharmacokinetics , Trypanosoma cruzi/metabolism
2.
Eur J Med Chem ; 147: 1-6, 2018 Mar 10.
Article in English | MEDLINE | ID: mdl-29421567

ABSTRACT

Polyamines play critical roles as regulators of cell growth and differentiation. In contrast with other protozoa, the human parasite Trypanosoma cruzi, the etiological agent of Chagas disease, is auxotrophic for polyamines. Therefore, their intracellular availability depends exclusively on polyamine transport and inhibition of these uptake processes can alter the viability of the parasite. The polyamine analogues used in this work were successfully tested as antiproliferative agents in cancer cells, bacteria, fungi and also showed a potent antiplasmodial effect. We evaluated the activity of these compounds on polyamine transport in T. cruzi and assessed the effects on parasite viability. Three polyamine derivatives, AMXT1501, Ant4 and Ant44, inhibited the putrescine transport in epimastigotes (the insect stage of T. cruzi) with calculated IC50 values of 2.43, 5.02 and 3.98 µM, respectively. In addition, only Ant4 and Ant44 inhibited spermidine transport with IC50 of 8.78 µM and 13.34 µM, respectively. The Ant4 analogue showed a high trypanocidal effect on trypomastigotes (the bloodstream stage of T. cruzi) with an IC50 of 460 nM, (SI = 12.7) while in epimastigotes the IC50 was significantly higher (16.97 µM). In addition, we studied the effect of the combination of benznidazole, a drug used in treating Chagas disease, with Ant4 on the viability of epimastigotes. The combined treatment produced a significant increase on the inhibition of parasites growth compared with individual treatments. In summary, these results suggest that Ant4, a putrescine conjugate, is a promising compound for the treatment of Chagas disease because it showed a potent trypanocidal effect via its inhibition of polyamine import.


Subject(s)
Polyamines/pharmacology , Trypanosoma cruzi/drug effects , Animals , Biological Transport/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Chlorocebus aethiops , Dose-Response Relationship, Drug , Molecular Structure , Polyamines/chemistry , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Spermidine/antagonists & inhibitors , Spermidine/metabolism , Structure-Activity Relationship , Trypanosoma cruzi/cytology , Trypanosoma cruzi/metabolism , Vero Cells
3.
J Inorg Biochem ; 162: 207-215, 2016 09.
Article in English | MEDLINE | ID: mdl-26723537

ABSTRACT

Cultures of Shewanella putrefaciens grown in medium containing 10mM 1,4-diamino-2-butanone (DBO) as an inhibitor of ornithine decarboxylase and 10mM 1,5-diaminopentane (cadaverine) showed the simultaneous biosynthesis of the macrocyclic dihydroxamic acids: putrebactin (pbH2), avaroferrin (avH2) and bisucaberin (bsH2). The level of DBO did not completely repress the production of endogenous 1,4-diaminobutane (putrescine) as the native diamine substrate of pbH2. The relative concentration of pbH2:avH2:bsH2 was 1:2:1, which correlated with the substrate selection of putrescine:cadaverine in a ratio of 1:1. The macrocycles were characterised using LC-MS as free ligands and as 1:1 complexes with Fe(III) of the form [Fe(pb)]+, [Fe(av)]+ or [Fe(bs)]+, with labile ancillary ligands in six-coordinate complexes displaced during ESI-MS acquisition; or with Mo(VI) of the form [Mo(O)2(pb)], [Mo(O)2(av)] or [Mo(O)2(bs)]. Chromium(V) complexes of the form [CrO(pb)]+ were detected from solutions of Cr(VI) and pbH2 in DMF using X-band EPR spectroscopy. Supplementation of S. putrefaciens medium with DBO and 1,3-diaminopropane, 1,6-diaminohexane or 1,4-diamino-2(Z)-butene (Z-DBE) resulted only in the biosynthesis of pbH2. The work has identified a native system for the simultaneous biosynthesis of a suite of three macrocyclic dihydroxamic acid siderophores and highlights both the utility of precursor-directed biosynthesis for expanding the structural diversity of siderophores, and the breadth of their coordination chemistry.


Subject(s)
Chromium/chemistry , Iron/chemistry , Molybdenum/chemistry , Peptides, Cyclic/biosynthesis , Putrescine/analogs & derivatives , Shewanella putrefaciens/metabolism , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cadaverine/metabolism , Coordination Complexes/chemistry , Diamines/pharmacology , Electron Spin Resonance Spectroscopy , Gene Expression , Hydroxamic Acids/antagonists & inhibitors , Ornithine Decarboxylase/genetics , Ornithine Decarboxylase/metabolism , Ornithine Decarboxylase Inhibitors/pharmacology , Peptides, Cyclic/antagonists & inhibitors , Putrescine/antagonists & inhibitors , Putrescine/biosynthesis , Putrescine/pharmacology , Shewanella putrefaciens/drug effects , Shewanella putrefaciens/genetics , Succinates/antagonists & inhibitors
4.
PLoS One ; 9(9): e107293, 2014.
Article in English | MEDLINE | ID: mdl-25251406

ABSTRACT

Polyamines are involved in the regulation of some Trichomonas vaginalis virulence factors such as the transcript, proteolytic activity, and cytotoxicity of TvCP65, a cysteine proteinase (CP) involved in the trichomonal cytotoxicity. In this work, we reported the putrescine effect on TvCP39, other CP that also participate in the trichomonal cytotoxicity. Parasites treated with 1,4-diamino-2-butanone (DAB) (an inhibitor of putrescine biosynthesis), diminished the amount and proteolytic activity of TvCP39 as compared with untreated parasites. Inhibition of putrescine biosynthesis also reduced ∼ 80% the tvcp39 mRNA levels according to RT-PCR and qRT-PCR assays. Additionally, actinomycin D-treatment showed that the tvcp39 mRNA half-life decreased in the absence of putrescine. However, this reduction was restored by exogenous putrescine addition, suggesting that putrescine is necessary for tvcp39 mRNA stability. TvCP39 was localized in the cytoplasm but, in DAB treated parasites transferred into exogenous putrescine culture media, TvCP39 was re-localized to the nucleus and nuclear periphery of trichomonads. Interestingly, the amount and proteolytic activity of TvCP39 was recovered as well as the tvcp39 mRNA levels were restored when putrescine exogenous was added to the DAB-treated parasites. In conclusion, our data show that putrescine regulate the TvCP39 expression, protein amount, proteolytic activity, and cellular localization.


Subject(s)
Cysteine Proteases/metabolism , Protozoan Proteins/metabolism , Putrescine/metabolism , Trichomonas vaginalis/metabolism , Active Transport, Cell Nucleus/drug effects , Blotting, Western , Cell Division/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cysteine Proteases/genetics , Gene Expression/drug effects , Microscopy, Confocal , Proteolysis/drug effects , Protozoan Proteins/genetics , Putrescine/analogs & derivatives , Putrescine/antagonists & inhibitors , Putrescine/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Trichomonas vaginalis/cytology , Trichomonas vaginalis/genetics
5.
J Vet Dent ; 30(3): 140-5, 2013.
Article in English | MEDLINE | ID: mdl-24371920

ABSTRACT

This study assessed proof-of-concept for use of polyamine inhibitor 2-diluoromethylornithine (DFMO) as a treatment for oral squamous cell carcinoma (SCC) in client-owned cats. Polyamine levels in tumor tissue and normal oral mucosa were quantified before and after treatment. DFMO was administered orally to 14 client-owned cats with histologically confirmed oral SCC. Patients were monitored for gastrointestinal, dermatologic, auditory, hematological, and biochemical abnormalities. Total polyamine levels in tumor tissue decreased after treatment, as did the specific polyamine putrescine in both tumor tissue and normal mucosa. Ototoxicity was observed in 5 of 6 cats receiving pre- and post-treatment brainstem auditory evoked potential tests. Subclinical thrombocytopenia was observed in 6 of 14 cats. One cat showed mild post-anesthetic tremors that resolved without treatment. Oral administration of DFMO at doses used in this study resulted in significantly decreased tumor polyamine levels without life-threatening clinical or hematological toxicities. Further studies are warranted to explore pathophysiology of polyamine biochemistry and use of polyamine inhibitors in treatment of cats with oral SCC.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/veterinary , Cat Diseases/drug therapy , Eflornithine/therapeutic use , Mouth Neoplasms/veterinary , Polyamines/antagonists & inhibitors , Animals , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Cat Diseases/pathology , Cats , Evoked Potentials, Auditory, Brain Stem/drug effects , Female , Hearing/drug effects , Hearing Loss/chemically induced , Male , Mouth Mucosa/pathology , Mouth Neoplasms/drug therapy , Mouth Neoplasms/pathology , Polyamines/analysis , Putrescine/analysis , Putrescine/antagonists & inhibitors , Spermidine/analysis , Spermidine/antagonists & inhibitors , Spermine/analysis , Spermine/antagonists & inhibitors , Thrombocytopenia/chemically induced
6.
Lik Sprava ; (5): 133-9, 2012.
Article in Ukrainian | MEDLINE | ID: mdl-23534282

ABSTRACT

This paper deals with antitumor properties of a fenugreek (Trigonella Foenum Graecum L.) as to the different genesis tumors--the Ca755 mouse mammary carcinoma and the Guerin's carcinoma in rats. Fenugreek powder was shown to inhibit (25-40 %) growth of certain tumors, decrease (27-63%) level of malone dialdehyde in liver, heart and kidney. Consumption of fenugreek was accompanied with decreased polyamines (spermine, spermidine, putrescine) content in tumor tissue. Inclusion of fenugreek to allowance was shown to improve certain blood value.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Carcinoma/drug therapy , Mammary Neoplasms, Experimental/drug therapy , Phytotherapy , Plant Preparations/therapeutic use , Powders/therapeutic use , Trigonella/chemistry , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Carcinoma/metabolism , Cisplatin/administration & dosage , Doxorubicin/administration & dosage , Drug Resistance, Neoplasm/drug effects , Female , Heart/drug effects , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Malondialdehyde/metabolism , Mammary Neoplasms, Experimental/metabolism , Mice , Plant Extracts/administration & dosage , Plant Preparations/pharmacology , Powders/pharmacology , Putrescine/antagonists & inhibitors , Rats , Spermidine/antagonists & inhibitors , Spermine/antagonists & inhibitors , Tumor Burden/drug effects
7.
Anticancer Res ; 28(5A): 2765-8, 2008.
Article in English | MEDLINE | ID: mdl-19035307

ABSTRACT

BACKGROUND: Mepacrine is an antiproliferative agent, characterised by an aliphatic chain similar to that of natural polyamines whose activation is closely associated with cell proliferation and may lead to malignant transformation and neurodegenerative diseases. This study aims to investigate a possible antagonism between mepacrine and polyamines in tumour proliferation. MATERIALS AND METHODS: MCF-7 and Vero cells were cultured in Eagle's minimum essential medium and then subjected to graded concentrations of putrescine, spermine and spermidine alone and in combination with mepacrine. Methyl thiazole tetrazolium test and Western-blotting were performed. RESULTS: Putrescine and spermidine at 0.5 mg/l significantly stimulated cell growth, whereas mepacrine treatment confirmed the enhanced p21 expression previously reported by a recent study and growth inhibition. When used in combination, mepacrine antagonized MCF-7 growth induced by polyamines. CONCLUSION: Our results suggest that mepacrine may represent a choice in the treatment of tumours induced by the modified concentration of polyamines.


Subject(s)
Antineoplastic Agents/pharmacology , Biogenic Polyamines/antagonists & inhibitors , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Quinacrine/pharmacology , Animals , Biogenic Polyamines/pharmacology , Blotting, Western , Cell Growth Processes/drug effects , Cell Line, Tumor , Chlorocebus aethiops , Drug Screening Assays, Antitumor , Humans , Putrescine/antagonists & inhibitors , Putrescine/pharmacology , Spermidine/antagonists & inhibitors , Spermidine/pharmacology , Spermine/antagonists & inhibitors , Spermine/pharmacology , Vero Cells
8.
APMIS ; 116(5): 361-71, 2008 May.
Article in English | MEDLINE | ID: mdl-18452426

ABSTRACT

Pseudomonas aeruginosa uses acyl-homoserine lactones to coordinate gene transcription in a process called quorum sensing (QS). The QS molecules C4-HSL and C12-oxo-HSL are synthesized from the universal precursor S-adenosyl methionine, which is also a precursor of polyamines in human cells. Polyamines are required for mitotic cell division and peak during this phase. The polyamine putrescine is synthesized by ornithine decarboxylase (ODC) as a rate-limiting step. The ODC enzyme concentration also peaks during the mitotic phase. This peak is mediated by translation of ODC mRNA by the ITAF45 protein, which translocates from the nuclear compartment to the cytoplasm in a phosphorylation-dependent manner. We observed that C12-HSL-treated human epidermal cells had a higher cytoplasm-to-nuclear ITAF45 protein concentration and this translocation was dependent on the dephosphorylation of ITAF45. Finally, C12-HSL-treated cells also had a time-course-dependent higher concentration of ODC mRNA. Based on these mitotic markers, more human cells were apparently trapped in the mitotic phase when treated with C12-HSL. This should normally imply higher levels of putrescine. However, C12-HSL-treated human cells had a significantly lower concentration of putrescine and displayed a lower cell proliferation rate. In conclusion, the P. aeruginosa autoinducer C12-oxo-HSL apparently arrests human cells in the mitotic phase by lowering the concentration of putrescine.


Subject(s)
Homoserine/analogs & derivatives , Pseudomonas aeruginosa/physiology , Putrescine/antagonists & inhibitors , Putrescine/biosynthesis , Amino Acid Sequence , Animals , Cell Division/physiology , Cell Line , Cell Proliferation , Growth Inhibitors/physiology , Homoserine/physiology , Humans , Lactones , Molecular Sequence Data , Ornithine Decarboxylase/physiology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/pathogenicity , Quorum Sensing/physiology
9.
J Plant Physiol ; 163(5): 497-505, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16473654

ABSTRACT

In legumes, the number of root nodules is controlled by a mechanism called autoregulation. Recently, we found that the foliar brassinosteroid (BR), a plant growth-regulating hormone, systemically regulates the nodule number in soybean plants. In the present study we report that such down-regulation of root nodule formation by a BR may occur through a change of the polyamine contents, with the experimental evidence as follows. The foliar contents of both spermidine (Spd) and spermine (Spm) in the super-nodulating soybean mutant, En6500, were always lower than those in its parent line, Enrei. This lower Spd and Spm content accompanied a striking accumulation of putrescine (Put) in the former plant. This finding indicates that Spd and Spm biosynthesis from their precursor Put is repressed in En6500. The foliar treatments with Spd or Spm of En6500 led to a reduction of both nodule number and root growth. On the other hand, foliar treatment with MDL74038, a specific inhibitor of Spd biosynthesis, apparently increased the root nodule number in Enrei. Foliar application of brassinolide (BL) of En6500 increased the leaf Spd level and reduced the nodule number. These results suggested that BL-induced Spd synthesis in shoots might suppress the root nodule formation.


Subject(s)
Cholestanols/pharmacology , Glycine max/drug effects , Plant Growth Regulators/pharmacology , Polyamines/pharmacology , Steroids, Heterocyclic/pharmacology , Brassinosteroids , Down-Regulation , Perchlorates/pharmacology , Plant Growth Regulators/metabolism , Plant Roots/drug effects , Plant Roots/growth & development , Plant Roots/physiology , Plant Shoots/drug effects , Plant Shoots/physiology , Plant Stems/anatomy & histology , Plant Stems/drug effects , Plant Stems/growth & development , Polyamines/antagonists & inhibitors , Polyamines/metabolism , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Putrescine/pharmacology , Glycine max/growth & development , Glycine max/metabolism , Spermidine/antagonists & inhibitors , Spermidine/metabolism , Spermidine/pharmacology , Spermine/antagonists & inhibitors , Spermine/metabolism , Spermine/pharmacology
10.
Amino Acids ; 29(3): 245-53, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16133764

ABSTRACT

Due to the similarity in transport characteristics of polyamines and the y+ basic amino acid system, we hypothesized that both substrates could be moving through a common carrier site. Competitive and cross inhibition experiments in intestinal epithelial cells revealed the possibility of a common transport site. N-ethylmalemide (NEM) inhibited both lysine and putrescine transport, confirming that both were carried by a y+ transporter. Overexpressing the y+ transporter CAT-1 in a polyamine transport-deficient cell line, CHO-MG, did not reconstitute polyamine-transport. Thus, polyamines are not traveling through CAT-1. To determine if lysine is carried by a polyamine transport site, an antizyme-overexpressing cell line was used. Antizyme overexpression decreased polyamine uptake by 50%; in contrast, lysine transport was unaffected. Therefore, lysine is not traveling through a polyamine transport site. It appears that polyamines and lysine are likely traveling through a common unknown y+ transport site.


Subject(s)
Cationic Amino Acid Transporter 1/metabolism , Epithelial Cells/metabolism , Intestinal Mucosa/cytology , Polyamines/metabolism , Absorption , Animals , CHO Cells , Cell Line , Cricetinae , Epithelial Cells/drug effects , Ethylmaleimide/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Lysine/antagonists & inhibitors , Lysine/metabolism , Mice , Polyamines/chemistry , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Rats , Spermidine/antagonists & inhibitors , Spermidine/metabolism
11.
J Periodontol ; 76(3): 443-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15857080

ABSTRACT

BACKGROUND: The polyamines spermidine, spermine, and putrescine are known to be deeply linked with growth processes, gene expression, and extracellular matrix synthesis. Their cellular content depends primarily on the activity of the enzyme ornithine decarboxylase. High levels of ornithine decarboxylase and polyamines have been found in proliferative, inflammatory, and neoplastic pathologies of the oral cavity and in gingival fluid. Difluoromethylornithine (DFMO) selectively inhibits ornithine decarboxylase, thus depleting polyamine content and preventing cell proliferation and synthesis activity. The aim of this study was to investigate whether DFMO treatment could modify the genes involved in cell proliferation and extracellular matrix turnover. METHODS: Fibroblasts derived from non-inflamed gingiva were maintained in Dulbecco's modified Eagle's medium (DMEM) plus alpha-difluoromethylornithine for 4 days. At 0, 24, 48, 72, and 96 hours cell number was assessed, polyamine levels were quantified with high performance liquid chromatography (HPLC) method, and transforming growth factor-beta1 (TGF-beta1), c-myc, matrix metalloproteinases (MMP)-1 and 2, collagen type I (COL-I) and tissue inhibitor of matrix metalloproteinases (TIMP)-1 were evaluated by reverse transcription polymerase chain reaction (RT-PCR). RESULTS: Fibroblasts treated with DFMO significantly decreased cell proliferation, ornithine decarboxylase activity, and putrescine levels at all treatment times, spermidine after 72 and 96 hours, and spermine after 96 hours of culture. Total polyamines decreased (P < or =0.01) at 96 hours after DFMO treatment, while c-myc, TGF-beta1, MMP-1 and 2, COL-I mRNA significantly increased. Conversely, TIMP-1 did not show any significant change. The polyamines trend was not correlated to c-myc, TGF-beta1, MMP-1 and -2, and TIMP-1 mRNA levels. Transforming growth factor-beta1 and c-myc mRNA expression were related and correlated to MMP-1 and 2, COL-I and TIMP-1 mRNA trend after DFMO treatment. CONCLUSIONS: Our data show that as the polyamine content decreases, TGF-beta1, c-myc, MMP-1 and -2, and COL-I mRNA levels increase, therefore a negative regulatory role of the polyamines on the mRNA expression could be suggested.


Subject(s)
Collagen Type I/analysis , Fibroblasts/metabolism , Gingiva/metabolism , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 2/analysis , Polyamines/antagonists & inhibitors , Proto-Oncogene Proteins c-myc/analysis , Transforming Growth Factor beta/analysis , Adult , Cell Count , Cell Proliferation , Cells, Cultured , Eflornithine/pharmacology , Enzyme Inhibitors/pharmacology , Extracellular Matrix/drug effects , Female , Fibroblasts/drug effects , Gingiva/cytology , Gingiva/drug effects , Humans , Ornithine Decarboxylase/analysis , Ornithine Decarboxylase Inhibitors , Putrescine/antagonists & inhibitors , RNA, Messenger/analysis , Spermidine/antagonists & inhibitors , Spermine/antagonists & inhibitors , Time Factors , Tissue Inhibitor of Metalloproteinase-1/analysis
12.
Anticancer Drugs ; 16(3): 229-41, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15711175

ABSTRACT

The natural polyamines are aliphatic cations with multiple functions and are essential for cell growth. Soon after the critical requirement of polyamines for cell proliferation was recognized, the metabolism of polyamines was pursued as a target for antineoplastic therapy. Initially, much attention was focused on the development of inhibitors of polyamine biosynthesis as a means to inhibit tumor growth. The best-characterized inhibitor is alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase. While compensatory mechanisms in polyamine metabolism reduce the effectiveness of DFMO as a single chemotherapeutic agent, it is currently undergoing extensive testing and clinical trials for chemoprevention and other diseases. There has been increasing interest over the last two decades in the cytotoxic response to agents that target the regulation of polyamine metabolism rather than directly inhibiting the metabolic enzymes in tumor cells. This interest resulted in the development of a number of polyamine analogs that exhibit effective cytotoxicity against tumor growth in preclinical models. The analogs enter cells through a selective polyamine transport system and can be either polyamine antimetabolites that deplete the intracellular polyamines or polyamine mimetics that displace the natural polyamines from binding sites, but do not substitute in terms of growth-promoting function. Synthesis of the first generation of symmetrically substituted bis(alkyl)polyamine analogs in the mid-1980s was based on the theory that polyamines may utilize feedback mechanisms to auto-regulate their synthesis. In the 1990s, unsymmetrically substituted bis(alkyl) polyamine analogs were developed. These compounds display structure-dependent and cell type-specific cellular effects and regulation on polyamine metabolism. More recently, a novel class of analogs has been synthesized, which include conformationally restricted, cyclic and long-chain oligoamine analogs. The development and use of these analogs have provided valuable information for understanding the molecular mechanisms of targeting the polyamine pathway as a means of cancer therapy.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Eflornithine/pharmacology , Neoplasms/metabolism , Polyamines/metabolism , Putrescine , Spermidine , Animals , Apoptosis/genetics , Apoptosis/physiology , Humans , Molecular Conformation , Neoplasms/drug therapy , Putrescine/antagonists & inhibitors , Putrescine/biosynthesis , Putrescine/physiology , Spermidine/antagonists & inhibitors , Spermidine/biosynthesis , Spermidine/physiology , Structure-Activity Relationship
13.
J Drug Target ; 12(1): 57-62, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15203912

ABSTRACT

The effects of etoposide on body weight, organ weights and the concentrations of putrescine, spermidine and spermine in 14 different tissues were examined in rats that had been given the drug for five consecutive days. Etoposide reduces all polyamines, which are associated with tumor cell growth, in the thymus and reduces polyamines of two kinds in the spleen, heart, small intestine, skeletal muscle and lung but it increases putrescine in the prostate and spleen, and spermine in the large intestine.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Etoposide/pharmacology , Polyamines/antagonists & inhibitors , Animals , Body Weight/drug effects , Chromatography, High Pressure Liquid , Male , Organ Size/drug effects , Organ Specificity , Polyamines/metabolism , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Rats , Rats, Sprague-Dawley
14.
Plant Physiol ; 135(1): 496-506, 2004 May.
Article in English | MEDLINE | ID: mdl-15133153

ABSTRACT

Although nitrogen (N) availability is known to alter constitutive resistance against herbivores, its influence on herbivore-induced responses, including signaling pathways, transcriptional signatures, and the subsequently elicited chemical defenses is poorly understood. We used the native tobacco, Nicotiana attenuata, which germinates in the postfire environment and copes with large changes in soil N during postfire succession, to compare a suite of Manduca sexta- and elicitor-induced responses in plants grown under high- and low-N (LN) supply rates. LN supply decreased relative growth rates and biomass by 35% at 40 d compared to high-N plants; furthermore, it also attenuated (by 39 and 60%) the elicitor-induced jasmonate and salicylate bursts, two N-intensive direct defenses (nicotine and trypsin proteinase inhibitors, albeit by different mechanisms), and carbon-containing nonvolatile defenses (rutin, chlorogenic acid, and diterpene glycosides), but did not affect the induced release of volatiles (cis-alpha-bergamotene and germacrene A), which function as indirect defenses. M. sexta and methyl jasmonate-induced transcriptional responses measured with a microarray enriched in herbivore-induced genes were also substantially reduced in plants grown under LN supply rates. In M. sexta-attacked LN plants, only 36 (45%) up-regulated and 46 (58%) down-regulated genes showed the same regulation as those in attacked high-N plants. However, transcriptional responses frequently directly countered the observed metabolic changes. Changes in a leaf's sensitivity to elicitation, an attacked leaf's waning ability to export oxylipin wound signals, and/or resource limitations in LN plants can account for the observed results, underscoring the conclusion that defense activation is a resource-intensive response.


Subject(s)
Nicotiana/genetics , Nitrogen/pharmacology , Plant Diseases/genetics , Transcription, Genetic/drug effects , Animals , Bridged Bicyclo Compounds/metabolism , Carbon/metabolism , Chlorogenic Acid/metabolism , Cyclopentanes/metabolism , Gene Expression Regulation, Plant/drug effects , Immunity, Innate/drug effects , Immunity, Innate/genetics , Immunity, Innate/physiology , Manduca/growth & development , Molecular Sequence Data , Nicotine/antagonists & inhibitors , Nitrogen/deficiency , Oxylipins , Plant Diseases/parasitology , Plant Proteins/genetics , Plant Proteins/metabolism , Protease Inhibitors/metabolism , Putrescine/antagonists & inhibitors , Rutin/metabolism , Salicylic Acid/metabolism , Sesquiterpenes, Germacrane/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Stress, Mechanical , Nicotiana/growth & development , Nicotiana/parasitology , Volatilization/drug effects
15.
Biochem Soc Trans ; 31(2): 381-3, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12653643

ABSTRACT

In colon cancer, the activities of polyamine-synthesizing enzymes and polyamine content are increased 3-4-fold over that found in the equivalent normal colonic mucosa, and polyamines have even been attributed as markers of neoplastic proliferation in the colon. Furthermore, and in contrast with all other cell systems in the body, normal and neoplastic cells in the colon are exposed to high concentrations of putrescine from the lumen, synthesized by colonic microflora. While such a high polyamine supply may be of benefit in non-neoplastic colonic mucosal growth, the role of luminal polyamines in colon cancer is a clear concern. Luminal polyamines are readily taken up by neoplastic colonocytes, they are utilized in full to support neoplastic growth, and their uptake is strongly up-regulated by the mitogens known to play an important role in colonic carcinogenesis. Inhibition of polyamine synthesis and their uptake, impaired utilization of exogenous polyamines, and enhanced catabolism of polyamines in neoplastic colonocytes are therefore logical approaches in the chemoprevention of colorectal cancer.


Subject(s)
Biogenic Polyamines/metabolism , Colonic Neoplasms/etiology , Antineoplastic Agents/pharmacology , Biogenic Polyamines/antagonists & inhibitors , Biomarkers, Tumor , Colonic Neoplasms/prevention & control , Humans , Putrescine/antagonists & inhibitors , Putrescine/metabolism
16.
Plant Physiol ; 131(1): 359-66, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12529543

ABSTRACT

Facultative parthenocarpy induced by the recessive mutation pat-2 in tomato (Lycopersicon esculentum Mill.) depends on gibberellins (GAs) and is associated with changes in GA content in unpollinated ovaries. Polyamines (PAs) have also been proposed to play a role in early tomato fruit development. We therefore investigated whether PAs are able to induce parthenocarpy and whether the pat-2 mutation alters the content and metabolism of PAs in unpollinated ovaries. Application of putrescine, spermidine, and spermine to wild-type unpollinated tomato ovaries (cv Madrigal [MA/wt]) induced partial parthenocarpy. Parthenocarpic growth of MA/pat-2 (a parthenocarpic near-isogenic line to MA/wt) ovaries was negated by paclobutrazol (GA biosynthesis inhibitor), and this inhibition was counteracted by spermidine. Application of alpha-difluoromethyl-ornithine (-Orn) and/or alpha-difluoromethyl-arginine (-Arg), irreversible inhibitors of the putrescine biosynthesis enzymes Orn decarboxylase (ODC) and Arg decarboxylase, respectively, prevented growth of unpollinated MA/pat-2 ovaries. Alpha-difluoromethyl-Arg inhibition was counteracted by putrescine and GA(3), whereas that of alpha-difluoromethyl-Orn was counteracted by GA(3) but not by putrescine or spermidine. In unpollinated MA/pat-2 ovaries, the content of free spermine was significantly higher than in MA/wt ovaries. ODC activity was higher in pat-2 ovaries than in MA/wt. Transcript levels of genes encoding ODC and spermidine synthase were also higher in MA/pat-2. All together, these results strongly suggest that the parthenocarpic ability of pat-2 mutants depends on elevated PAs levels in unpollinated mutant ovaries, which correlate with an activation of the ODC pathway, probably as a consequence of elevated GA content in unpollinated pat-2 tomato ovaries.


Subject(s)
Flowers/growth & development , Gibberellins/metabolism , Polyamines/metabolism , Solanum lycopersicum/growth & development , Carboxy-Lyases/antagonists & inhibitors , Carboxy-Lyases/genetics , Carboxy-Lyases/metabolism , Eflornithine/pharmacology , Flowers/drug effects , Flowers/metabolism , Fruit/growth & development , Gibberellins/pharmacology , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Mutation , Ornithine Decarboxylase/genetics , Ornithine Decarboxylase/metabolism , Ornithine Decarboxylase Inhibitors , Polyamines/antagonists & inhibitors , Polyamines/pharmacology , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Putrescine/pharmacology , RNA, Plant/genetics , RNA, Plant/metabolism , Reproduction/physiology , Spermidine/metabolism , Spermidine/pharmacology , Spermidine Synthase/genetics , Spermidine Synthase/metabolism , Spermine/metabolism , Spermine/pharmacology , Triazoles/pharmacology
17.
Am J Physiol Lung Cell Mol Physiol ; 284(1): L179-86, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12388342

ABSTRACT

Hypoxic pulmonary vascular remodeling in rats is associated with increased polyamine transport in pulmonary artery smooth muscle cells (PASMCs). We therefore defined constitutive and hypoxia-induced polyamine transport properties of rat cultured PASMCs and determined the impact of polyamine transport blockade on hypoxia-induced accumulation of p38 MAP kinase. PASMCs exhibited polyamine transport pathways that were characterized by Michaelis-Menten kinetics. RNA synthesis inhibition attenuated while inhibition of protein synthesis increased polyamine uptake, thus suggesting regulation by ornithine decarboxylase-antizyme. The presence of two transporters with overlapping selectivities, one for putrescine and another for all three polyamines, was inferred by cross-competition studies and by findings that only putrescine uptake was sodium dependent and that hypoxia caused a selective, time-dependent induction of putrescine transport. The pathophysiological significance of augmented putrescine import was suggested by the observation that polyamine transport inhibition suppressed hypoxia-induced p38 MAP kinase phosphorylation. These results indicate that rat PASMCs express two polyamine transporters and that a specific increase in the putrescine uptake pathway is necessary for hypoxia-induced activation of p38 MAP kinase.


Subject(s)
Hypoxia/metabolism , Lysine/analogs & derivatives , Mitogen-Activated Protein Kinases/metabolism , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Pulmonary Artery/metabolism , Putrescine/metabolism , Spermine/analogs & derivatives , Animals , Binding, Competitive , Biological Transport/drug effects , Biological Transport/physiology , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Enzyme Activation/physiology , Lysine/pharmacology , Male , Phosphorylation/drug effects , Polyamines/pharmacokinetics , Putrescine/antagonists & inhibitors , Putrescine/pharmacokinetics , Rats , Rats, Sprague-Dawley , Sodium/physiology , Spermine/pharmacology , Time Factors , p38 Mitogen-Activated Protein Kinases
18.
Cardiovasc Pathol ; 9(5): 273-80, 2000.
Article in English | MEDLINE | ID: mdl-11064274

ABSTRACT

OBJECTIVE: Ornithine decarboxylase (ODC) is an initial rate-limiting enzyme in the synthesis of polyamines (putrescine, spermidine, and spermine) that play a role in cell growth and differentiation. Recent studies have shown that spermidine and spermine cause injury to a variety of cells including myocytes in vitro. In this investigation, we used alpha-difluoromethylornithine (DFMO), a specific and irreversible inhibitor of ODC activity and polyamine synthesis to test the hypothesis that polyamines contribute to myocardial injury in rat. METHODS: Male Sprague Dawley rats were treated with (i) saline (0.2 ml/day, s.c.), (ii) isoproterenol (ISO) (5 mg/kg/day for 8 days, s.c.) to produce necrotizing myocardial injury, or with (iii) DFMO + ISO. DFMO was started 2 days before the initiation of ISO and both ISO and DFMO were continued until the end of the experimental period. Myocardial injury was assessed by determining the increased release of creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) into the plasma, and by morphometric analysis of the lesion area in heart sections stained with Gomori trichrome. RESULTS: ISO induced the release of CPK and LDH by 6 hr and 24 hr, respectively, and produced subendocardial necrosis, which was both acute and resolving following 8 days of ISO. DFMO treatment inhibited ISO-induced increases in (i) ODC activity and putrescine and spermidine levels in heart, (ii) CPK and LDH activity in plasma, and (iii) the area of subendocardial lesions. CONCLUSIONS: These observations suggest that polyamines are one of the intracellular factors that contribute to ISO-mediated cardiac injury in the rat.


Subject(s)
Adrenergic beta-Agonists/toxicity , Eflornithine/therapeutic use , Enzyme Inhibitors/therapeutic use , Isoproterenol/toxicity , Myocardial Infarction/prevention & control , Myocardium/metabolism , Polyamines/metabolism , Animals , Biomarkers , Creatine Kinase/blood , Male , Myocardial Infarction/chemically induced , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardium/pathology , Ornithine Decarboxylase Inhibitors , Polyamines/antagonists & inhibitors , Putrescine/antagonists & inhibitors , Putrescine/biosynthesis , Rats , Rats, Sprague-Dawley , Spermidine/antagonists & inhibitors , Spermidine/biosynthesis , Spermine/antagonists & inhibitors , Spermine/biosynthesis
19.
Plant Physiol ; 124(1): 431-9, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10982456

ABSTRACT

The possible involvement of polyamines (PAs) in the chilling tolerance of cucumber (Cucumis sativus L. cv Jinchun No. 3 and cv Suyo) was investigated. Plants with the first expanded leaves were exposed to 3 degrees C or 15 degrees C in the dark for 24 h (chilling), and then transferred to 28 degrees C/22 degrees C under a 12-h photoperiod for another 24 h (rewarming). Chilling-tolerant cv Jinchun No. 3 showed a marked increase of free spermidine (Spd) in leaves, once during chilling and again during rewarming. Putrescine increased significantly during rewarming, but the increase of spermine was slight. Any of these PAs did not increase in chilling-sensitive cv Suyo during either period. PA-biosynthetic enzyme activities appear to mediate these differences between cultivars. Pretreatment of Spd to cv Suyo prevented chill-induced increases in the contents of hydrogen peroxide in leaves and activities of NADPH oxidases and NADPH-dependent superoxide generation in microsomes and alleviated chilling injury. Pretreatment of methylglyoxal-bis-(guanylhydrazone), a PA biosynthesis inhibitor, to chilled cv Jinchun No. 3 prevented Spd increase and enhanced microsomal NADPH oxidase activity and chilling injury. The results suggest that Spd plays important roles in chilling tolerance of cucumber, probably through prevention of chill-induced activation of NADPH oxidases in microsomes.


Subject(s)
Cucumis sativus/physiology , Photoperiod , Putrescine/metabolism , Spermidine/metabolism , Adaptation, Physiological , Cucumis sativus/enzymology , Cucumis sativus/metabolism , Enzyme Inhibitors/pharmacology , Freezing , Hydrogen Peroxide/metabolism , Microsomes/enzymology , Microsomes/metabolism , Mitoguazone/pharmacology , NADP/metabolism , Oxidation-Reduction , Plant Leaves/enzymology , Plant Leaves/metabolism , Plant Leaves/physiology , Putrescine/antagonists & inhibitors , Putrescine/biosynthesis , Reactive Oxygen Species/metabolism , Spermidine/antagonists & inhibitors , Spermidine/biosynthesis , Superoxides/metabolism
20.
J Neurochem ; 74(3): 1106-11, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10693942

ABSTRACT

The polyamine system is very sensitive to different pathological states of the brain and is perturbed after CNS injury. The main modifications are significant increases in ornithine decarboxylase activity and an increase in tissue putrescine levels. Previously we have shown that the specific polyamine oxidase (PAO) inhibitor N1,N4-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72527) reduced the tissue putrescine levels, edema, and infarct volume after transient focal cerebral ischemia in spontaneously hypertensive rats and traumatic brain injury of Sprague-Dawley rats. In the present study, N1-acetyl-spermidine accumulation was greater in injured brain regions compared with sham or contralateral regions following inhibition of PAO by MDL 72527. This indicates spermidine/spermine-N1-acetyltransferase (SSAT) activation after CNS injury. The observed increase in N1-acetylspermidine levels at 1 day after CNS trauma paralleled the decrease in putrescine levels after treatment with MDL 72527. This suggests that the increased putrescine formation at 1 day after CNS injury is mediated by the SSAT/PAO pathway, consistent with increased SSAT mRNA after transient ischemia.


Subject(s)
Brain Injuries/metabolism , Brain/metabolism , Spermidine/analogs & derivatives , Animals , Arterial Occlusive Diseases/metabolism , Blood-Brain Barrier , Cerebral Arteries , Gerbillinae , Ischemic Attack, Transient/metabolism , Male , Prosencephalon/blood supply , Putrescine/analogs & derivatives , Putrescine/antagonists & inhibitors , Putrescine/metabolism , Putrescine/pharmacokinetics , Putrescine/pharmacology , Rats , Rats, Inbred SHR , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Spermidine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...